Arylsulfonanilide ureas

Details Arylsulfonanilide ureas Arylsulfonanilide ureas

2006-06-13

2006-06-13

Stockton, Laura L. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S597000, C514S407000, C514S471000, C514S371000, C514S381000, C514S383000, C514S237500, C544S159000, C548S371700, C548S265600, C548S196000, C548S251000, C548S140000, C548S365400, C549S493000, C564S049000

Reexamination Certificate

active

07060718

ABSTRACT:
The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents.

REFERENCES:
patent: 1955207 (1934-04-01), Stotter et al.
patent: 2358365 (1944-09-01), Tullar
patent: 2402623 (1946-06-01), Hester et al.
patent: 3034955 (1962-05-01), Frick et al.
patent: 4881969 (1989-11-01), Saupe et al.
patent: 4883914 (1989-11-01), Alvarado et al.
patent: 4900867 (1990-02-01), Wilkes et al.
patent: 5143937 (1992-09-01), Lang et al.
patent: 5189211 (1993-02-01), Sato et al.
patent: 5250549 (1993-10-01), Yoshino et al.
patent: 5385931 (1995-01-01), Bigg et al.
patent: 5387709 (1995-02-01), Lardy et al.
patent: 5780483 (1998-07-01), Widdowson et al.
patent: 6214880 (2001-04-01), Houze
patent: 6355628 (2002-03-01), Schwendner et al.
patent: 6583165 (2003-06-01), Houze
patent: 622 494 (1935-11-01), None
patent: 36 23 184 (1988-01-01), None
patent: 0 391 799 (1990-10-01), None
patent: 0 469 901 (1992-02-01), None
patent: 0 472 449 (1992-02-01), None
patent: 0472053 (1999-02-01), None
patent: 2456731 (1980-12-01), None
patent: 859 345 (1961-01-01), None
patent: 938 890 (1963-10-01), None
patent: 1 189 720 (1970-04-01), None
patent: 1 242 057 (1971-08-01), None
patent: 1 306 564 (1973-02-01), None
patent: 2001-526255 (2001-12-01), None
patent: WO 97/30677 (1997-08-01), None
patent: WO 98/05315 (1998-02-01), None
patent: WO 99/24407 (1999-05-01), None
patent: WO 99/32433 (1999-07-01), None
Golub et al., Science, vol. 286, Oct. 15, 1999, pp. 531-537.
Fielding et al, “Synthesis and Reactions of 4-sulpho-2,3,5,6-Tetrafluorobenzoic Acid”;Journal of Fluorine Chemistry, vol. 59, No. 1, pp. 15-31 (1992).
Raibekas et al. “Affinity Probing of Flavin Binding Sites. 2. Identification of Reactive cysteine in the Flavin Domain ofEscherichia coliDNA Photolyase”;Biochemistry, vol. 33, No. 42, pp. 12656-12664 (1994).
Shealy et al. “2-Haloethylating Agents for Cancer Chemotherapy. 2-Haloethyl Sulfonates”;Journal of Medicinal Chemistry, vol. 26, pp. 1168-1173 (Aug. 1983).
Olander et al., “A Study of the binding of two sulfonamides to Carbonic Anhydrase”;Journal of American Chemical Society, vol. 95, No. 5, pp. 1616-1621 (Mar. 7, 1973).
Hawkinson, et al; “Studies of the Solvolysis of 2-Adamantyl Pentafluorobenzenesulfonate: A ΥPFBSScale”;The Journal of Organic Chemistry, Aug. 1988, vol. 53, No. 16, pp 3857-3860.
Chemical Abstracts, vol. 50, No. 1, Jan. 10, 1956 Columbus, Ohio, US; abstract No. 217g, V.O. Lukashevich; “Sulphonation of halogen-substituted benzene derivatives. formation of anhydrides of corresponding sulphonic acids” col. 217; XP002083056 see abstract & Doklady Akad. Nauk S.S.S.R., vol. 99, 1954, pp. 995-998.
Chemical Abstracts, vol. 74, No. 14, Apr. 5, 1971, Columbus, Ohio, US; abstract No. 65535a, D. Simov, Et al.: “Preparation of azo dyes containing amobile chlorine atom in the benzene ring” p. 81: XP002083055 see abstract & IZV. OTD. KHIM. NAUKI, BULG. AKAD. NAUK, vol. 3, No. 1, 1970, pp. 69-82.
I.C. Poppoff, et al.: “Antimalarial agents. 8. Ring-substituted bis-(4-aminophenyl) sulphones and their precursors”Journal of Medicinal Chemistry, vol. 14, No. 12, Dec. 1971, pp. 1166-1169, XP002083052 Washington, DC, US see compounds V, VIII,X, XI, XIII, XVII, XIX, XXVIII, XXXII, XXXVI-XXXVIII, XLI, XLII<XLIV<XLV.
G.E. Chivers, et al.: “Studies in the chemistry of polyhalogenobenzene compounds. The synthesis and reactivity of 2,3,5,6- and 2,3,4,5-tetrachlorobenzenesulphonyl chlorides and related compounds”;Australian Journal of Chemistry, vol. 29, No. 7, Jul. 1976, pp. 1572-1582, XP002083174, Melbourne, AU.
P.G. DeBenedetti, et al.; “Quantitative structure-activity analysis in dihydropteroate synghase inhibition by sulphones. Comparison with sulphanilamides”Journal of Medicinal Chemistry, vol. 30, No. 3, Mar. 1987, pp. 459-464. XP002083053 Washington, DC, US.
V.N. Babushkin, et al.: “Influence of substituents on the frequency of stretching vibrations of sulphur-containing bridging groups in diphenyl systems”Journal of General Chemistry of the USSR, vol. 58, No. 7, pt. 2, Jul. 1988., pp. 1457-1460. XP002083054 New York, US.
Yoshimoto and Hansch, “Correlation Analysis of Baker's Studies on Enzyme Inhibition. 2. Chymotrypsin, Thymidine Phosphorylase, Uridine Phosphorylase, Thymidylate Synthetase, Cytosine Nucleoside Deaminase, Dihydrofolate Reductase, malate Dehydrogenase, Glutamate Dehydrogenase, Lactate Dehydrogenase, and Glyceraldehyde-phosphate Dehydrogenase.”;Journal of Medicinal Chemistry(1976) vol. 19, No. 1 pp 71-98.
Bai, et al.; “Identification of the cystein Residue of β-Tubulin Alkylated by the Antimitotic Agent 2,4-Dichlorobenzyl Thiocyanate, Facilitated by Separationof the Protein subunits of Tubulin by Hydrophobic column chromatography”;Biochemistry1989, vol. 28, pp. 5606-5612.

Affiliated with

Also associated with

Rating

Arylsulfonanilide ureas does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Arylsulfonanilide ureas, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylsulfonanilide ureas will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3674209